scholarly article | Q13442814 |
P2093 | author name string | De Flora A | |
Guida L | |||
Zocchi E | |||
Benatti U | |||
Polvani C | |||
P2860 | cites work | Enzymatic degradation of uric acid by uricase-loaded human erythrocytes | Q34481274 |
Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5'-nucleotidase in human erythrocytes | Q36248051 | ||
Encapsulation of adriamycin in human erythrocytes | Q37399860 | ||
A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil | Q39863354 | ||
Phase I study of 5-fluorodeoxyuridine plus cytosine arabinoside infusions in patients with solid tumors | Q39892748 | ||
Encapsulation of exogenous agents in erythrocytes and the circulating survival of carrier erythrocytes | Q40214899 | ||
Characteristics of a pyrimidine-specific 5'-nucleotidase in human erythrocytes | Q40343321 | ||
In vitro correction of erythrocyte glucose 6-phosphate dehydrogenase (G6PD) deficiency | Q41128733 | ||
High-yield entrapment of proteins into erythrocytes | Q41326312 | ||
Construction of glucose oxidase-loaded human erythrocytes: a model of oxidative cytotoxicity. | Q43840706 | ||
The removal of leukocytes and platelets from whole blood. | Q44677074 | ||
A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. | Q52700835 | ||
Nucleoside transport in human erythrocytes. A simple carrier with directional symmetry and differential mobility of loaded and empty carrier. | Q52713959 | ||
Physiological effects of high-P50 erythrocyte transfusion on piglets. | Q53680867 | ||
Hepatic or splenic targeting of carrier erythrocytes: a murine model | Q69440231 | ||
Large-scale entrapment of drugs into resealed red blood cells using a continuous-flow dialysis system | Q69480253 | ||
Osmotic fragility of drug carrier erythrocytes | Q70054182 | ||
Hepatic pharmacokinetics of glutaraldehyde-treated methotrexate-loaded carrier erythrocytes in dogs | Q70457011 | ||
Circulating carrier erythrocytes: slow-release vehicle for an antileukemic drug, cytosine arabinoside | Q70575637 | ||
Morphological alterations of red blood cells in favism. A study with Nomarski optics and electron microscopy | Q70598219 | ||
Glutaraldehyde-treated carrier erythrocytes for organ targeting of methotrexate in dogs | Q71593566 | ||
Resealed red blood cells as a new blood transfusion product | Q93568216 | ||
Incorporation of allosteric effectors of hemoglobin in red blood cells. Physiological effects | Q93568223 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | floxuridine | Q5462356 |
human erythrocyte | Q111535219 | ||
P304 | page(s) | 3145-3149 | |
P577 | publication date | 1988-05-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes | |
P478 | volume | 85 |
Q40804186 | Carrier erythrocytes. Clinical pharmacokinetic considerations |
Q28547179 | Design strategies and applications of circulating cell-mediated drug delivery systems |
Q37902115 | Drug delivery by red blood cells |
Q46777954 | Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes |
Q90524204 | Erythrocytes as Carriers: From Drug Delivery to Biosensors |
Q37707194 | Formulation and Drug Loading Features of Nano-Erythrocytes. |
Q42073716 | Free ADP-ribose in human erythrocytes: pathways of intra-erythrocytic conversion and non-enzymic binding to membrane proteins |
Q24528271 | Homogeneous pyrimidine nucleotidase from human erythrocytes: enzymic and molecular properties |
Q67478665 | Interactions of Carboplatin with Human Erythrocytes and Murine Erythroleukemic Cells |
Q36994110 | Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines |
Q24320120 | Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides |
Q37638602 | Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection. |
Search more.